Neurocritical Care
Antiepileptic
Drug
Dosing
Common
Adverse Effects
Considerations
Pentobarbital
10 mg/kg (typically over
15β30 min, depending on
blood pressure); typically need
additional 5 to 10 mg/kg boluses
to full loading dose of 25β30
mg/kg; 1 to 3 mg/kg/hr infusion
Sedation,
hypotension,
respiratory
depression,
constipation,
cardiac depression,
immunosuppression
IV formulation contains propylene
glycol; target is burst suppression;
several drug-drug interactions
Midazolam
high-dose
infusion
0.05β2 mg/kg/hr
Sedation,
hypotension,
respiratory depression
Potential tachyphylaxis, target is
burst suppression
Propofol
20β200 mcg/kg/min, titrate by
5 mcg/kg/min; use caution
when administering doses >
80 mcg/kg/min for extended
periods
Sedation,
hypotension,
respiratory
depression,
pancreatitis, propofol-
related infusion
syndrome
Target is burst suppression; provides
1.1 kcal/mL; hypertriglyceridemia at
higher doses
Ketamine
0.5β10 mg/kg/hr
Excitation,
hypertension, possible
neurotoxicity,
hallucinations
May be more effective in prolonged
refractory status epilepticus. May
cause hypotension in patients with
decreased shock index; consider
IV fluid volume with high-dose
infusions
AES = American Epilepsy Society; BID = twice daily; IM = intramuscular(ly); NCS = Neurocritical Care Society; PE = phenytoin equivalents; QID = four times daily.
Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012;17:3-23; Glauser T, Shinnar S, Gloss D,
et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society.
Epilepsy Curr 2016;16:48-61.
Patient Case
A 37-year-old man (weight 75 kg) is admitted to the emergency department with meningitis. On admis-
sion, his GCS score decreases from E3-M6-V1T to E1-M5-V1T over 10 minutes, and his nurse notices
facial twitching. An EEG is ordered. Current medications include famotidine 20 mg intravenously every 12
hours, heparin 5000 units subcutaneously every 8 hours, docusate 100 mg nasogastrically twice daily, and
a supplemental vitamin infusion for potential alcohol withdrawal. Which is the best acute therapy for this
patientβs suspected seizure activity?